Publicação:
The hemolytic uremic syndrome as a complication of adriamycin nephropathy

dc.contributor.authorViero, Rosa Marlene [UNESP]
dc.contributor.authorSoares, Vitor A. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:19:36Z
dc.date.available2014-05-27T11:19:36Z
dc.date.issued1998-08-13
dc.description.abstractRats treated with two injections of adriamycin (week 0 and week 12) developed glomerusclerosis and severe tubulointerstitial lesions as described in the literature. In addition, a number of glomerular alterations were present. These included capillary loop dilation, insudation of eosinophilic material, necrosis, duplication of the glomerular basement membrane, severe mesangiolysis with disruption of the mesangial matrix and segmental double- contours. The renal arterioles and interlobular arteries showed endothelial cell swelling. The subendothelial space was infiltrated by fibrinoid material and there was intensive fibrinoid necrosis of the wall of both arteries and arterioles extending into the glomerular tuft. These alterations were very similar to those observed in the hemolytic uremic syndrome. This observation suggests that the two injections of adriamycin, with a long interval in between them, might induce renal lesions similar to those observed in the hemolytic uremic syndrome.en
dc.description.affiliationDepartment of Pathology Botucatu Medical School, Botucatu
dc.description.affiliationDepartment of Internal Medicine Division of Nephrology Botucatu Medical School, Botucatu
dc.description.affiliationBotucatu Medical School Depto. Internal Medicine Division of Nephrology, P O Box 584, Botucatu, DP, 18618-970
dc.description.affiliationUnespDepartment of Pathology Botucatu Medical School, Botucatu
dc.description.affiliationUnespDepartment of Internal Medicine Division of Nephrology Botucatu Medical School, Botucatu
dc.description.affiliationUnespBotucatu Medical School Depto. Internal Medicine Division of Nephrology, P O Box 584, Botucatu, DP, 18618-970
dc.format.extent565-571
dc.identifierhttp://dx.doi.org/10.3109/08860229809045148
dc.identifier.citationRenal Failure, v. 20, n. 4, p. 565-571, 1998.
dc.identifier.doi10.3109/08860229809045148
dc.identifier.issn0886-022X
dc.identifier.lattes1453564171333848
dc.identifier.scopus2-s2.0-0031853810
dc.identifier.urihttp://hdl.handle.net/11449/65495
dc.language.isoeng
dc.relation.ispartofRenal Failure
dc.relation.ispartofjcr1.440
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectAdriamycin
dc.subjectHemolytic uremic syndrome
dc.subjectdoxorubicin
dc.subjecthydroxyproline
dc.subjectserum albumin
dc.subjectsodium chloride
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectcontrolled study
dc.subjectcreatinine clearance
dc.subjectglomerulosclerosis
dc.subjectglomerulus basement membrane
dc.subjectglomerulus capillary
dc.subjecthemolytic uremic syndrome
dc.subjectinterstitial nephritis
dc.subjectkidney artery
dc.subjectkidney disease
dc.subjectmale
dc.subjectmesangium
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectrat
dc.subjectAnimals
dc.subjectAntineoplastic Agents
dc.subjectDoxorubicin
dc.subjectGlomerulonephritis
dc.subjectHemolytic-Uremic Syndrome
dc.subjectKidney Glomerulus
dc.subjectMale
dc.subjectNephritis, Interstitial
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectTime Factors
dc.titleThe hemolytic uremic syndrome as a complication of adriamycin nephropathyen
dc.typeArtigo
dcterms.licensehttp://informahealthcare.com/userimages/ContentEditor/1255620309227/Copyright_And_Permissions.pdf
dspace.entity.typePublication
unesp.author.lattes1453564171333848
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentClínica Médica - FMBpt
unesp.departmentPatologia - FMBpt

Arquivos